Exploring FDA's Pilot Program for AI-Driven Drug EvaluationExploring FDA's Pilot Program for AI-Driven Drug Evaluation
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started
Back to feedPost
Hunter's avatar
Hunter Schmidt
• May 26
FDA initiates pilot program for evaluating AI-designed drugs
Over 200 drugs developed using artificial intelligence are currently in clinical trials around the world. To date, none have received FDA approval.
The Food and Drug Administration has introduced a pilot initiative aimed at determining how to assess AI-generated evidence in drug applications. Ten companies have been selected for an accelerated, interactive review process.
Development in the AI pharmaceutical sector has progressed more rapidly than existing regulatory guidelines. This situation now defines the state of AI-driven drug development.
ai
Back to feed
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started